Pham Quang X 4

What Happened
Pham Quang X, a reported 10% owner of Cadrenal Therapeutics, sold a total of 17,124 shares in three open-market transactions between June 11 and June 15, 2026, generating approximately $70,351 in proceeds. The individual transactions were: 1,462 shares at a weighted average price of $4.12 (≈ $6,023), 12,996 shares at $3.94 (≈ $51,204), and 3,666 shares at $3.58 (≈ $13,124). These sales were made under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction dates & weighted-average prices:
  • 2026-06-11: 1,462 shares @ $4.12 (range reported 4.09–4.16)
  • 2026-06-12: 12,996 shares @ $3.94 (range reported 3.80–4.23)
  • 2026-06-15: 3,666 shares @ $3.58 (range reported 3.22–3.81)
• Total shares sold: 17,124; total proceeds: ≈ $70,351.
• Trading plan: Sales executed pursuant to a Rule 10b5-1 plan adopted September 25, 2025.
• Ownership note: Quang Pham is trustee of The PVBQ Living Trust and has sole voting and dispositive power over trust shares; the trust’s sole beneficiary is his child.
• Filing: Form 4 filed 2026-06-15 (Accession 0001213900-26-068981) covering transactions through 2026-06-15. The filing appears timely based on the transaction dates.
• Shares owned after transaction: not disclosed in the provided excerpt.

Context
These were outright sales by a 10% owner under a pre-set trading plan; such transactions are often routine and governed by plan parameters rather than immediate market views. For retail investors, purchases typically carry stronger signals than routine, pre-scheduled sales.